v3.26.3
Segment Information - Schedule of segment net loss and significant segment expenses (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2026
Jun. 30, 2026
Mar. 31, 2026
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Sep. 30, 2026
Sep. 30, 2025
Segment Reporting [Line Items]                
Research and Development Expense $ 17,443     $ 16,927     $ 56,362 $ 47,148
General and Administrative Expense 6,015     4,963     18,615 15,372
Total operating expenses 23,458     21,890     74,977 62,520
Net loss (21,347) $ (22,285) $ (25,241) (19,035) $ (19,984) $ (15,906) (68,873) (54,925)
Operating Segments [Member]                
Segment Reporting [Line Items]                
Non-employee-related general and administrative expenses 2,058     2,000     7,194 6,914
Other segment expenses1 [1] 2,372     410     6,207 1,140
Net loss 21,347     19,035     68,873 54,925
Operating Segments [Member] | Employee Related Expenses [Member]                
Segment Reporting [Line Items]                
Research and Development Expense 4,049     3,265     12,218 9,588
General and Administrative Expense 1,597     1,295     4,944 4,150
Operating Segments [Member] | Research and Pre-clinical Expenses [Member]                
Segment Reporting [Line Items]                
Research and Development Expense 1,857     1,871     5,340 5,609
Operating Segments [Member] | Clinical and Development Expenses [Member]                
Segment Reporting [Line Items]                
Research and Development Expense 7,937     5,749     26,062 15,845
Operating Segments [Member] | Non-ClinicalScienceExpenses[Member]                
Segment Reporting [Line Items]                
Research and Development Expense 805     1,225     1,715 3,128
Operating Segments [Member] | Chemistry, Manufacturing, and Control Expenses [Member]                
Segment Reporting [Line Items]                
Research and Development Expense $ 672     $ 3,220     $ 5,193 $ 8,551
[1] Other segment expenses include expenses not captured in the primary categories above, such as stock-based compensation, depreciation and amortization, interest income, interest expense and income tax expense.